The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2020-02-28
- Target Recruit Count
- 40
- Registration Number
- NCT01697800
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
- Conditions
- Prostate Cancer Adenocarcinoma in Situ
- Interventions
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2019-03-28
- Target Recruit Count
- 29
- Registration Number
- NCT01696877
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).
- Conditions
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Interventions
- First Posted Date
- 2012-09-19
- Last Posted Date
- 2019-03-28
- Target Recruit Count
- 3
- Registration Number
- NCT01688401
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
- Conditions
- Renal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)Melanoma
- Interventions
- Radiation: PET/CT imaging with [18F] 2-deoxy-2-(18F)fluoro-D-glucose (FDG)
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2019-02-08
- Target Recruit Count
- 20
- Registration Number
- NCT01666353
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
- Conditions
- Gray Zone LymphomaCD20+, B-cell LymphomasTransformed Lymphoma/DLBCL/PMBCLMantle Cell LymphomaNon-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL)Hodgkin's Disease
- Interventions
- Biological: Rituximab
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2021-10-26
- Target Recruit Count
- 56
- Registration Number
- NCT01665768
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
- Conditions
- Glioblastoma
- Interventions
- Procedure: Lymphocyte harvesting & reinfusion
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2018-11-07
- Target Recruit Count
- 10
- Registration Number
- NCT01653834
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma
- Conditions
- Metastatic Colorectal Adenocarcinoma
- Interventions
- First Posted Date
- 2012-07-12
- Last Posted Date
- 2022-08-10
- Target Recruit Count
- 6
- Registration Number
- NCT01639131
- Locations
- 🇳🇱
VU Medisch Centrum, Amsterdam, Netherlands
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Center for Cancer Research, NCI, Bethesda, Maryland, United States
MRI for Assessing Prostate Cancer Response
- Conditions
- Prostate Cancer
- Interventions
- Other: MRI imaging
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2024-06-07
- Target Recruit Count
- 20
- Registration Number
- NCT01607008
- Locations
- 🇺🇸
The Sidney Kimmel Comprehsensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
- Conditions
- Pancreatic Cancer
- Interventions
- Radiation: Stereotactic Body RadiationBiological: GVAX Pancreas Vaccine
- First Posted Date
- 2012-05-10
- Last Posted Date
- 2024-08-14
- Target Recruit Count
- 19
- Registration Number
- NCT01595321
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
A Feasibility Study of a Modular Video Augmentation System for Image-Guided Skull Base Surgery
- Conditions
- Value of Video Augmentation NavigationFeasibility of Video Augmentation System
- Interventions
- Device: Video Augmentation
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2016-12-01
- Target Recruit Count
- 1
- Registration Number
- NCT01591954
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States